3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Sarcoma
1
NET
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Oxaliplatin
95
Fluorouracil
84
Capecitabine
75
Gemcitabine
72
Leucovorin
68
Nivolumab
67
Bevacizumab
63
pembrolizumab
60
Magnetic Resonance Spectroscopy
52
Specimen Handling
50
Irinotecan
50
durvalumab
46
Radiotherapy
42
atezolizumab
40
Cisplatin
39
Paclitaxel
37
Biopsy
37
130-nm albumin-bound paclitaxel
34
Cetuximab
30
Carboplatin
27
Albumin-Bound Paclitaxel
26
Taxes
24
Drug Therapy
20
dehydroftorafur
19
Radiation
19
Ipilimumab
19
tislelizumab
18
Surgical Procedures, Operative
17
Standard of Care
17
Docetaxel
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Radionuclide Imaging
×
Gastrointestinal
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled